XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies - (Tables)
3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Schedule of Concentration of Risk, by Risk Factor and Significant Payer For each significant payor and customer, revenue as a percentage of total revenue and accounts receivable as a percentage of total accounts receivable are as follows:
 
 Revenue
 Three Months Ended
March 31,
 20222021
Medicare20 %18 %
Medicare Advantage15 %12 %
Blue Shield13 %12 %

 Accounts Receivable
 March 31, 2022December 31, 2021
 
United Healthcare20 %18 %
Blue Shield19 %19 %
Disaggregation of Revenue
The following table includes the Company's revenues as disaggregated by payor and customer category (in thousands):
 
 Three Months Ended March 31,
 20222021
Revenue:
Healthcare insurers$6,423 $6,027 
Government2,120 2,009 
Client(1)1,591 1,965 
Other(2)260 286 
Janssen (SIMPONI®)
— 300 
Total revenue$10,394 $10,587 
(1)Includes hospitals, other laboratories, etc.
(2)Includes patient self-pay.
Schedule of Restricted Cash and Cash Equivalents
Cash, cash equivalents and restricted cash presented in the accompanying condensed statements of cash flows consist of the following (in thousands):
 
 March 31, 2022December 31, 2021
Cash and cash equivalents$89,751 $99,442 
Restricted cash100 100 
$89,851 $99,542 
Schedule of Cash and Cash Equivalents
Cash, cash equivalents and restricted cash presented in the accompanying condensed statements of cash flows consist of the following (in thousands):
 
 March 31, 2022December 31, 2021
Cash and cash equivalents$89,751 $99,442 
Restricted cash100 100 
$89,851 $99,542 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
Potentially dilutive securities not included in the calculation of diluted net loss per share because to do so would be anti-dilutive are as follows (in common stock equivalent shares):
 
 Three Months Ended March 31,
 20222021
Warrants to purchase common stock409,108 426,827 
Common stock options2,002,039 2,041,580 
Restricted stock units878,575 185,000 
Employee stock purchase plan6,929 2,869 
Total3,296,651 2,656,276